Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

SynapDx Autism Gene Expression Analysis Study (STORY)

ClinicalTrials.gov ID: NCT01810341

Public ClinicalTrials.gov record NCT01810341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 3:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

SynapDx Autism Spectrum Disorder Gene Expression Analysis Study

Study identification

NCT ID
NCT01810341
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
SynapDx
Industry
Enrollment
880 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Months to 60 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2013
Primary completion
Jun 30, 2014
Completion
Nov 30, 2014
Last update posted
Dec 16, 2014

2013 – 2014

United States locations

U.S. sites
18
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Melmed Center Scottsdale Arizona 85254
Miller Children's Hospital Long Beach California 90806
UC Davis MIND Institute Sacramento California 95817
Emory University Decatur Georgia 30033
Rush Medical Center Chicago Illinois 60612
Riley Hospital for Children Indianapolis Indiana 46202
Children's Hospital Boston Boston Massachusetts 02115
Lurie Center Massachusetts General Hospital Lexington Massachusetts 02421
Mount Sinai School of Medicine/Seaver Center New York New York 10029
Institute for Behavioral Research on Staten Island Staten Island New York 10314
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27517
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Nationwide Children's Hospital Columbus Ohio 43205
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Nashville Tennessee 37212
Baylor College of Medicine/Texas Children's Hospital Houston Texas 77054
Seattle Children's Seattle Washington 98121

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01810341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2014 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01810341 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →